Cargando…

Polygenic risk of Parkinson disease is correlated with disease age at onset

OBJECTIVE: We have investigated the polygenic architecture of Parkinson disease (PD) and have also explored the potential relationship between an individual's polygenic risk score and their disease age at onset. METHODS: This study used genotypic data from 4,294 cases and 10,340 controls obtain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escott‐Price, Valentina, Nalls, Mike A., Morris, Huw R., Lubbe, Steven, Brice, Alexis, Gasser, Thomas, Heutink, Peter, Wood, Nicholas W., Hardy, John, Singleton, Andrew B., Williams, Nigel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737223/ https://www.ncbi.nlm.nih.gov/pubmed/25773351 http://dx.doi.org/10.1002/ana.24335

Ejemplares similares

Cooperative Genome-Wide Analysis Shows Increased Homozygosity in Early Onset Parkinson's Disease
por: Simón-Sánchez, Javier, et al.
Publicado: (2012)

Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance
por: Lubbe, Steven J., et al.
Publicado: (2016)

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease
por: Lubbe, S.J., et al.
Publicado: (2016)

Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease
por: Lesage, Suzanne, et al.
Publicado: (2015)

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
por: Liu, Hui, et al.
Publicado: (2022)

Polygenic risk and pleiotropy in neurodegenerative diseases
por: Bellou, Eftychia, et al.
Publicado: (2020)

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
por: Mok, Kin Y, et al.
Publicado: (2016)

Assessing the relationship between monoallelic PRKN mutations and Parkinson’s risk
por: Lubbe, Steven J, et al.
Publicado: (2021)

Polygenic risk and hazard scores for Alzheimer's disease prediction
por: Leonenko, Ganna, et al.
Publicado: (2019)

Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions
por: Baker, Emily, et al.
Publicado: (2020)

Genome Wide Assessment of Young Onset Parkinson’s Disease from Finland
por: Hernandez, Dena G., et al.
Publicado: (2012)

Measuring heritable contributions to Alzheimer’s disease: polygenic risk score analysis with twins
por: Karlsson, Ida K., et al.
Publicado: (2022)

Age-dependent effect of APOE and polygenic component on Alzheimer's disease
por: Bellou, Eftychia, et al.
Publicado: (2020)

From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review
por: Harrison, Judith R., et al.
Publicado: (2020)

Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
por: Escott-Price, V., et al.
Publicado: (2018)

Polygenic Risk Scores Contribute to Personalized Medicine of Parkinson’s Disease
por: Dehestani, Mohammad, et al.
Publicado: (2021)

The Birth of the Modern Era of Parkinson’s Disease Genetics
por: Singleton, Andrew B., et al.
Publicado: (2017)

Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
por: Blauwendraat, Cornelis, et al.
Publicado: (2021)

Variation in Recent Onset Parkinson’s Disease: Implications for Prodromal Detection
por: Swallow, Diane M.A., et al.
Publicado: (2016)

Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
por: Leonenko, Ganna, et al.
Publicado: (2021)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
por: Brown, Emmeline E., et al.
Publicado: (2021)

The Parkinson's Disease Mendelian Randomization Research Portal
por: Noyce, Alastair J., et al.
Publicado: (2019)

Early Onset Parkinson’s Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report
por: Norman, Brendan P., et al.
Publicado: (2017)

Genome-wide association studies for Alzheimer’s disease: bigger is not always better
por: Escott-Price, Valentina, et al.
Publicado: (2022)

The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2023)

Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing
por: Jansen, Iris E., et al.
Publicado: (2017)

Analysis of rare Parkinson’s disease variants in millions of people
por: Pitz, Vanessa, et al.
Publicado: (2023)

Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
por: Mencacci, Niccolò E., et al.
Publicado: (2014)

Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
por: Malek, Naveed, et al.
Publicado: (2017)

Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels
por: Ibanez, Laura, et al.
Publicado: (2017)

Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencing
por: Crawford, Karen, et al.
Publicado: (2022)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
por: Billingsley, Kimberley J., et al.
Publicado: (2019)

Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
por: Pavelka, L., et al.
Publicado: (2022)

POLARIS: Polygenic LD‐adjusted risk score approach for set‐based analysis of GWAS data
por: Baker, Emily, et al.
Publicado: (2018)

Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
por: Liu, Ganqiang, et al.
Publicado: (2021)

Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson’s Disease
por: Tan, Manuela M.X., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4gpdb1irl73v1oc96cplacdnqh